maca root
Lepidium meyenii, known as maca or Peruvian ginseng, is an edible herbaceous biennial plant of the family Brassicaceae that is native to South America in the high Andes mountains of Peru and Bolivia. It was rediscovered for commercial purposes at the Meseta de Bombón plateau close to Lake Junin in the late 1980s. It is grown for its fleshy hypocotyl that is fused with a taproot, which is typically dried but may also be freshly cooked as a root vegetable. As a cash crop, it is primarily exported as a powder that may be raw or processed further as a gelatinized starch or as an extract. If dried, it may be processed into a flour for baking or as a dietary supplement. — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Earliest trial started Apr 1, 2005 (NCT00181961)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLepidium meyenii ↗
Also known as
- maca root
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00568126 | Phase 3 | Nov 1, 2007 | Harvard University, National Institutes of Health (NIH) |
| NCT00575328 | Phase 3 | Nov 1, 2007 | Brain & Behavior Research Foundation, Harvard University |
| NCT00181961 | Phase 3 | Apr 1, 2005 | Harvard University |
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 3 | 3 | 1 | 2005 |
| Brain & Behavior Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2007 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2007 |